XML 54 R44.htm IDEA: XBRL DOCUMENT v3.23.2
Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Sep. 30, 2022
Finite Lived Intangible Assets [Line Items]          
Net Carrying Amount $ 10,687,000   $ 10,687,000   $ 11,962,000
Amortization expense 400,000 $ 400,000 1,300,000 $ 1,300,000  
Novartis          
Finite Lived Intangible Assets [Line Items]          
Gross Carrying Amount 24,857,000   24,857,000   24,857,000
Accumulated Amortization 14,170,000   14,170,000   12,895,000
Impairment 0   0   0
Net Carrying Amount 10,687,000   10,687,000   11,962,000
Novartis | Patents          
Finite Lived Intangible Assets [Line Items]          
Gross Carrying Amount 21,728,000   21,728,000   21,728,000
Accumulated Amortization 12,933,000   12,933,000   11,770,000
Impairment 0   0   0
Net Carrying Amount $ 8,795,000   $ 8,795,000   $ 9,958,000
Useful Lives 14 years   14 years   14 years
Novartis | License          
Finite Lived Intangible Assets [Line Items]          
Gross Carrying Amount $ 3,129,000   $ 3,129,000   $ 3,129,000
Accumulated Amortization 1,237,000   1,237,000   1,125,000
Impairment 0   0   0
Net Carrying Amount $ 1,892,000   $ 1,892,000   $ 2,004,000
Useful Lives 21 years   21 years   21 years